Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.

被引：0
|
作者：
van der Kolk, DM
Vellenga, E
Scheffer, GL
Muller, M
Bates, SE
Scheper, RJ
de Vries, EGE
机构：
[1] Univ Groningen Hosp, Groningen, Netherlands
[2] Free Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] Univ Wageningen, Wageningen, Netherlands
[4] NIH, NCI, Bethesda, MD USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2989
引用
收藏
页码：715A / 716A
页数：2
相关论文
共 50 条
  • [31] The Prognostic Role of Smac/DIABLO Protein Expression in Acute Myeloid Leukemia.
    Pluta, Agnieszka
    Wrzesien-Kus, Agata
    Cebula, Barbara
    Wolska, Anna
    Szmigielska-Kaplon, Anna
    Czemer-ska, Magdalena
    Smolewski, Piotr
    Robak, Tadeusz
    Wierzbowska, Agnieszka
    BLOOD, 2009, 114 (22) : 1030 - 1030
  • [32] Aberrant expression of angiotensin in acute myeloid leukemia.
    Pinto, RP
    Wang, KK
    Khoury, H
    Schimmer, AD
    Minden, MD
    BLOOD, 2003, 102 (11) : 577A - 577A
  • [33] Aberrant gene expression in acute myeloid leukemia.
    Pinto, RP
    Wang, KK
    Schimmer, AD
    Minden, MD
    BLOOD, 2001, 98 (11) : 93A - 93A
  • [34] FLT3 internal tandem duplications in adults with de novo acute myeloid leukemia.
    Xavier, SG
    Hassan, R
    Clementino, NCD
    Tabak, DG
    Spector, N
    Zalcberg, IR
    BLOOD, 2004, 104 (11) : 191B - 191B
  • [35] Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-γ1 in acute myeloid leukemia cells
    Walter, RB
    Raden, BW
    Thompson, J
    Flowers, DA
    Kiem, HP
    Bernstein, ID
    Linenberger, ML
    LEUKEMIA, 2004, 18 (11) : 1914 - 1917
  • [36] The clinical significance of the multidrug resistance proteins expression in patients with acute myeloid leukemia.
    Podolak-Dawidziak, M
    Dus, D
    Kielbinski, M
    Paprocka, M
    Kuliszkowicz-Janus, M
    Kuliczkowski, K
    BLOOD, 2004, 104 (11) : 186B - 186B
  • [37] Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-γ1 in acute myeloid leukemia cells
    R B Walter
    B W Raden
    J Thompson
    D A Flowers
    H-P Kiem
    I D Bernstein
    M L Linenberger
    Leukemia, 2004, 18 : 1914 - 1917
  • [38] Expression of breast cancer resistance protein (BCRP) in esophageal cancers (EC)
    Bharthuar, A.
    Khoury, T.
    Haas, K. N.
    Mashtare, T.
    Black, J.
    Baer, M.
    Yang, G.
    Khushalani, N.
    Iyer, R. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] p73 mutations and expression in adult de novo acute myelogenous leukemia.
    Stirewalt, DL
    Cluman, B
    Appelbaum, FR
    Willman, CL
    Radich, JP
    BLOOD, 1998, 92 (10) : 221A - 221A
  • [40] Expression and prognostic significance of survivin in de novo acute myeloid leukemia (AML).
    Adida, C
    Recher, C
    Raffoux, E
    Daniel, MT
    Taksin, AL
    Rousselot, P
    Sigaux, F
    Degos, L
    Altieri, DC
    Dombret, H
    BLOOD, 2000, 96 (11) : 698A - 698A
12345